Stock BPTH BIO-PATH HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bio-Path Holdings, Inc.

Equities

BPTH

US09057N4097

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.68 USD +1.71% Intraday chart for Bio-Path Holdings, Inc. -37.53% -71.06%
Apr. 19 Bio-Path Closes $1.2 Million Share Offering MT
Apr. 18 Bio-Path Holdings, Inc. Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1B Clinical Trial of Bp1002 in Refractory/Relapsed Acute Myeloid Leukemia Patients CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 29.5 15.9 26.99 12.02 5.719 4.195 - -
Enterprise Value (EV) 1 29.5 15.9 26.99 12.02 5.719 4.195 4.195 4.195
P/E ratio -2.47 x -1.24 x -2.43 x -0.79 x -0.01 x -0.14 x -0.15 x -0.15 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA - - - - - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 185 227 358 398 618 1,565 - -
Reference price 2 159.8 70.00 75.40 30.20 9.260 2.680 2.680 2.680
Announcement Date 3/5/20 3/9/21 3/10/22 3/30/23 3/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - - -
EBITDA - - - - - - - -
EBIT 1 -8.693 -10.91 -10.44 -13.9 -15.84 -12.88 -13.52 -13.72
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 -8.599 -10.88 -10.44 -13.87 -16.08 -12.82 -13.44 -13.56
Net income 1 -8.599 -10.88 -10.44 -13.87 -16.08 -12.82 -13.44 -13.56
Net margin - - - - - - - -
EPS 2 -64.80 -56.60 -31.00 -38.20 -672.6 -18.71 -18.41 -17.69
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 3/5/20 3/9/21 3/10/22 3/30/23 3/7/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 - - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - - -
EBIT 1 -2.069 -4.117 -3.359 -3.01 -3.546 -3.986 -5.292 -4.242 -3.276 -3.033 -3.082 -3.156 -3.255 -3.383
Operating Margin - - - - - - - - - - - - - -
Earnings before Tax (EBT) 1 -2.069 -4.116 -3.359 -3.008 -3.535 -3.966 -5.273 -4.234 -3.199 -3.372 -3.062 -3.139 -3.241 -3.373
Net income 1 -2.069 -4.116 -3.359 -3.008 -3.535 -3.966 -5.273 -4.234 -3.199 -3.372 -3.062 -3.139 -3.241 -3.373
Net margin - - - - - - - - - - - - - -
EPS 2 -5.800 -11.80 -9.400 -8.400 -9.800 -10.60 -13.20 -10.60 -6.400 -84.60 -4.540 -4.600 -4.710 -4.850
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/10/21 3/10/22 5/16/22 8/15/22 11/14/22 3/30/23 5/11/23 8/14/23 11/14/23 3/7/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 3/5/20 3/9/21 3/10/22 3/30/23 3/7/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.68 USD
Average target price
40 USD
Spread / Average Target
+1,392.54%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
BIO-PATH HOLDINGS, INC. Stock Bio-Path Holdings, Inc.
-71.06% 4.2M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. BPTH Stock
  4. Financials Bio-Path Holdings, Inc.